PALLEIKO BENJAMIN L (CFO and Secretary) sold 2.2% of their position (10.03K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $156.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/24/2026ACC: 0001366244-26-000004
Officer· CFO and Secretary
Since Sep 2018
-10.03K
Net shares
Net seller
$156.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
23.25K acquired · 33.28K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+23.25K
Price / share
—
Trade value
—
% of position
5.4%
2/21/2026
429.67K→452.92K
Common Stock
Direct
Shares
−10.03K
Price / share
$15.57
Trade value
$156.20K
% of position
2.2%
2/23/2026
452.92K→442.88K
Total
Net shares
+13.22K
Net value
-$156.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2026 | M · Option Exercise | +23.25K | — | — | 5.4% | 429.67K | 452.92K |
| Common Stock Direct | 2/23/2026 | S · Sale | −10.03K | $15.57 | $156.20K | 2.2% | 452.92K | 442.88K |
| Total | +13.22K | -$156.20K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
23.25K shares
Shares
−23.25K
Strike price
Held after
279K
Exercisable
—
2/21/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock23.25K shares | 2/21/2026 | M · Option Exercise | −23.25K | — | 279K |